Geneos Wealth Management’s Haleon HLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.66K Buy
713
+8
+1% +$74 ﹤0.01% 2110
2026
Q1
$7.05K Sell
705
-334
-32% -$3.48K ﹤0.01% 2077
2025
Q4
$10.5K Hold
1,039
– – ﹤0.01% 1948
2025
Q3
$9.32K Sell
1,039
-3,602
-78% -$34.7K ﹤0.01% 1981
2025
Q2
$48.1K Sell
4,641
-205
-4% -$2.16K ﹤0.01% 1593
2025
Q1
$49.9K Buy
4,846
+1,203
+33% +$11.8K ﹤0.01% 1475
2024
Q4
$34.8K Buy
+3,643
New +$35.6K ﹤0.01% 1467

Other funds holding HLN

Geneos Wealth Management's HLN Position: Q2 2026 in Review

Geneos Wealth Management increased its Haleon (HLN) stake by 1.1% in Q2 2026, buying an estimated $74 and bringing the position to 713 shares worth $6.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

Geneos Wealth Management first reported a position in HLN in Q4 2024 and has held it in 7 quarters since. The position peaked at $49.9K in Q1 2025. 646 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • Geneos Wealth Management held 713 shares of Haleon worth $6.66K as of Q2 2026.
  • Geneos Wealth Management bought 8 Haleon shares in Q2 2026, an estimated $74.
  • Haleon made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2110 holding.
  • Geneos Wealth Management first reported a position in Haleon in Q4 2024 and has held it in 7 quarters since.
  • Geneos Wealth Management's Haleon position peaked at $49.9K in Q1 2025.
  • 646 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.